Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Meta-Analysis
. 2024 Jul 31;16(1):94.
doi: 10.1186/s13073-024-01364-x.

Meta-analysis identifies common gut microbiota associated with multiple sclerosis

Affiliations
Meta-Analysis

Meta-analysis identifies common gut microbiota associated with multiple sclerosis

Qingqi Lin et al. Genome Med. .

Abstract

Background: Previous studies have identified a diverse group of microbial taxa that differ between patients with multiple sclerosis (MS) and the healthy population. However, interpreting findings on MS-associated microbiota is challenging, as there is no true consensus. It is unclear whether there is gut microbiota commonly altered in MS across studies.

Methods: To answer this, we performed a meta-analysis based on the 16S rRNA gene sequencing data from seven geographically and technically diverse studies comprising a total of 524 adult subjects (257 MS and 267 healthy controls). Analysis was conducted for each individual study after reprocessing the data and also by combining all data together. The blocked Wilcoxon rank-sum test and linear mixed-effects regression were used to identify differences in microbial composition and diversity between MS and healthy controls. Network analysis was conducted to identify bacterial correlations. A leave-one-out sensitivity analysis was performed to ensure the robustness of the findings.

Results: The microbiome community structure was significantly different between studies. Re-analysis of data from individual studies revealed a lower relative abundance of Prevotella in MS across studies, compared to controls. Meta-analysis found that although alpha and beta diversity did not differ between MS and controls, a higher abundance of Actinomyces and a lower abundance of Faecalibacterium were reproducibly associated with MS. Additionally, network analysis revealed that the recognized negative Bacteroides-Prevotella correlation in controls was disrupted in patients with MS.

Conclusions: Our meta-analysis identified common gut microbiota associated with MS across geographically and technically diverse studies.

Keywords: Faecalibacterium; Prevotella; Meta-analysis; Microbiota; Multiple sclerosis.

PubMed Disclaimer

Conflict of interest statement

YZ holds shares at General Biomics Inc. HT has, in the last 5 years, received research support from the Canada Research Chair Program, the National Multiple Sclerosis Society, the Canadian Institutes of Health Research, the Multiple Sclerosis Society of Canada, the Multiple Sclerosis Scientific Research Foundation, and the EDMUS Foundation (“Fondation EDMUS contre la sclérose en plaques”) and, in addition, in the last 5 years, has had travel expenses or registration fees prepaid or reimbursed to present at CME conferences from the Consortium of MS Centres (2018), National MS Society (2018), ECTRIMS/ACTRIMS (2017–2022), and American Academy of Neurology (2019). Speaker honoraria are either declined or donated to an MS charity or to an unrestricted grant for use by HT’s research group. EEL has received honoraria over the last 5 years for consulting for Bristol Myers Squibb, Genentech, TG Therapeutics, NGM Bio, Janssen, Biogen, Genzyme, Alexion, EMD Serono, Celgene, and Teva. She has received research support from Genentech, the National Institutes of Health (NIH K23 NS107624 and KL2 TR001862), the Race to Erase MS, and the Robert E Leet and Clara Guthrie Patterson Trust. She is an assistant editor for Annals of Neurology. The remaining authors declare that they have no competing interests.

Figures

Fig. 1
Fig. 1
Common microbiota revealed by individual study analysis. a Summary of microbiota analysis at the microbial community level for each study. Significant differences are demonstrated by different colors. The sizes of the circles represent scale of -log10 p-value. b Genera that are significantly different in MS vs controls by Wilcoxon rank-sum test or DESeq2 test. Significant genera identified in at least two studies are shown in descending order from top to bottom by its shared frequency. For each individual study, the sizes of the circles represent mean relative abundance of the genera, and the colors of the circles represent statistically higher (blue) or lower (orange) of the relative abundance of the genera in MS, compared to controls. Taxonomy at the class level for each genus is indicated on the class column. Different shapes in the class column indicate the abundance of the genera are consistently (triangles) and inconsistently (circles) higher or lower in MS in at least two studies, compared to controls
Fig. 2
Fig. 2
Microbiota variation across all studies. a Abundance and prevalence of 652 genera identified in 7 studies. Left Y-axis shows number of studies that detect a given genus (frequency); right Y-axis represents the relative abundance of each genus in a study. Several relatively high abundant genera are labeled in the plot. b Principal component analysis of samples from all seven studies based on Bray-Curtis distance; different studies are color-coded and group (MS vs controls) is indicated by different shapes. Boxplots at the bottom and at the right show PC1 and PC2 loadings for different studies or group (MS vs controls). Studies are significantly different in both PC1 and PC2 (p < 0.001). Group (MS and controls) is significantly different in PC2 after controlling for study effect (p = 0.0002). c Percent of variance that is significantly contributed by each factor
Fig. 3
Fig. 3
Common microbiota revealed by meta-analysis. a Alpha and beta diversity in MS and controls. Diversity is not statistically different between MS and controls (p = 0.72 for Bray-Curtis dissimilarity; p = 0.57 for richness; p = 0.63 for Shannon diversity). b Significantly different genera between MS and controls identified by meta-analysis. Fifteen genera are significantly different between MS and controls after controlling for the “study” factor. Mean and standard error for each genus are illustrated. Class level taxonomy for each genus is indicated next to the genus. c Results of leave-one-out sensitivity analysis
Fig. 4
Fig. 4
Disruption of Bacteroides-Prevotella correlative network in MS. The network is constructed using correlations with p-value less than 0.05 and correlation coefficient larger than 0.2. Red lines represent positive correlations and blue lines represent negative correlations; The width of line varies by absolute value of correlation coefficient, and the nodes size represents relative abundance of genera. a, b Correlations shared between MS and controls. Nine positive correlations are shared in MS (a) and controls (b). c Correlations that are unique in controls. d Correlations that are unique in MS

References

    1. Mirza A, Forbes JD, Zhu F, Bernstein CN, Van Domselaar G, Graham M, Waubant E, Tremlett H. The multiple sclerosis gut microbiota: a systematic review. Mult Scler Relat Disord. 2020;37:101427. 10.1016/j.msard.2019.101427 - DOI - PubMed
    1. Cantoni C, Lin Q, Dorsett Y, Ghezzi L, Liu Z, Pan Y, Chen K, Han Y, Li Z, Xiao H, et al. Alterations of host-gut microbiome interactions in multiple sclerosis. EBioMedicine. 2022;76:103798. 10.1016/j.ebiom.2021.103798 - DOI - PMC - PubMed
    1. Katz Sand I, Zhu Y, Ntranos A, Clemente JC, Cekanaviciute E, Brandstadter R, Crabtree-Hartman E, Singh S, Bencosme Y, Debelius J, et al. Disease-modifying therapies alter gut microbial composition in MS. Neurol Neuroimmunol Neuroinflamm. 2019;6:e517. 10.1212/NXI.0000000000000517 - DOI - PMC - PubMed
    1. Cekanaviciute E, Yoo BB, Runia TF, Debelius JW, Singh S, Nelson CA, Kanner R, Bencosme Y, Lee YK, Hauser SL, et al. Gut bacteria from multiple sclerosis patients modulate human T cells and exacerbate symptoms in mouse models. Proc Natl Acad Sci U S A. 2017;114:10713–8. 10.1073/pnas.1711235114 - DOI - PMC - PubMed
    1. Chen J, Chia N, Kalari KR, Yao JZ, Novotna M, Paz Soldan MM, Luckey DH, Marietta EV, Jeraldo PR, Chen X, et al. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls. Sci Rep. 2016;6:28484. 10.1038/srep28484 - DOI - PMC - PubMed

Publication types

Substances

LinkOut - more resources